Key Takeaways
- Staphyt has welcomed four new minority shareholders: Unigrains, Bpifrance, Nord Est Partenaires, and IRD Invest.
- The investment supports Staphyt’s diversification, international expansion, and external growth strategy.
- The company operates in 17 countries across three continents, with over 50 trial sites and nearly 600 employees.
- Staphyt has completed 16 acquisitions since its founding, including four in Brazil between 2021 and 2022.
- Leadership sees this investment as a step toward strengthening Staphyt’s market presence and service offerings.
Strategic Investment to Support Staphyt’s Growth
Staphyt, a global provider of agronomic research services, has entered a new phase of development by opening its capital to Unigrains, Bpifrance, Nord Est Partenaires, and IRD Invest. The transaction aims to facilitate diversification, expansion into new geographic regions, and further external growth initiatives.
Founded in 1989 in Inchy-en-Artois, France, Staphyt specializes in field trials, laboratory analyses, and regulatory consulting services for the agrochemical, biosolutions, and seed sectors. The company currently operates more than 50 proprietary trial sites across 17 countries, serving international clients in Europe, North America, and South America.
With this investment, Staphyt plans to extend its services into adjacent markets, including regulatory consulting for REACH and cosmetic analyses. The company also aims to strengthen its global presence and continue acquiring companies in a still-fragmented industry.
Staphyt Leadership Perspective on the Investment
Arthur Boisleux, President of Staphyt, emphasized the importance of this partnership: “With the arrival of Unigrains, Bpifrance, Nord Est Partenaires, and IRD Invest in our capital, we will benefit from the financial resources and strategic expertise of complementary investors who share our vision for the development of our company. We are delighted to begin this new phase in service of our mission, which consists of providing our clients with unique and tailor-made solutions with a common objective: to sustainably feed the world of tomorrow.”
Investor Statements on the Partnership
Unigrains
Julien Becquet and Virginie Boutrouille, Investment Managers at Unigrains, highlighted Staphyt’s strong market position: “Thanks to its integrated model, comprehensive offer, geographic coverage, and extensive experience in acquisitions, Staphyt is well-positioned to continue consolidating its market segments. For Unigrains, this investment supports French agronomic excellence and the development of solutions for resilient and sustainable agriculture.”
Bpifrance
Pierre de Miscault, Investment Director at Bpifrance, commented on the company’s global reach: “We are pleased to support the development of Staphyt, a French family-owned business with a global reach. This transaction will allow the group to expand its services, strengthen its geographic coverage, and better serve international clients looking for an integrated partner.”
Nord Est Partenaires
Paul-Antoine Grasset, Private Equity Director, and Mathis Gillet, Investment Manager at Nord Est Partenaires, expressed their confidence in Staphyt’s innovation: “Nord Est Partenaires is proud to support a major player in the French agronomic industry and contribute to the sustainability of agriculture through innovation. Our investment will help Staphyt continue its growth and innovation strategy.”
IRD Invest
Grégory Sion, Investment Director at IRD Invest, reflected on their long-term relationship with Staphyt: “After our initial experience with Staphyt in 2010, we are pleased to participate in this capital growth operation alongside the Boisleux family. The ambition remains the same: to strengthen Staphyt’s expertise and international reach while maintaining high service quality and strong added value.”
